The Frequency and Clinical Features of Hypersensitivity Reactions to Antiepileptic Drugs in Children: A Prospective Study

被引:23
|
作者
Guvenir, Hakan [1 ]
Misirlioglu, Emine Dibek [1 ]
Civelek, Ersoy [1 ]
Toyran, Muge [1 ]
Buyuktiryaki, Betul [1 ]
Ginis, Tayfur [1 ]
Capanoglu, Murat [1 ]
Gurkas, Esra [2 ]
Guven, Alev [2 ]
Kocabas, Can Naci [3 ]
机构
[1] Univ Hlth Sci, Ankara Child Hlth & Dis Hematol Oncol Training &, Dept Pediat Allergy & Immunol, Ankara, Turkey
[2] Univ Hlth Sci, Ankara Child Hlth & Dis Hematol Oncol Training &, Dept Pediat Neurol, Ankara, Turkey
[3] Mugla Sitki Kocman Univ, Fac Med, Dept Childrens Hlth & Dis, Div Pediat Allergy & Immunol, 48000 Kotekli Campus, Mugla, Turkey
关键词
Antiepileptic drugs; Child; DRESS; Epilepsy; Hypersensitivity; S[!text type='JS']JS[!/text; Patch test; STEVENS-JOHNSON-SYNDROME; CUTANEOUS ADVERSE-REACTIONS; TOXIC EPIDERMAL NECROLYSIS; CARBAMAZEPINE HYPERSENSITIVITY; ERYTHEMA MULTIFORME; HLA-A-ASTERISK-31/01; EPILEPSY; UPDATE; RISK; RASH;
D O I
10.1016/j.jaip.2018.02.018
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Antiepileptic drugs (AEDs) can cause hypersensitivity reactions during childhood. Studies report a wide clinical spectrum of reactions with AED use, ranging from a mild rash to severe cutaneous reactions. OBJECTIVE: To determine the prevalence and clinical features of AED hypersensitivity reactions during childhood. METHODS: Patients in our pediatric neurology clinic who were prescribed an AED for the first time between November 2015 and November 2016 were monitored and those who developed skin rash during this period were evaluated. RESULTS: A total of 570 patients were evaluated. The median age of the patients was 8.86 (interquartile range, 4.2-13.7) years, and 55.8% (318) of patients were male. The most frequently used AEDs were valproic acid (42%, n [285) and carbamazepine (20.4%, n [116). Hypersensitivity reactions to AEDs developed in 5.4% of patients. Of these patients, 71% (29) had cutaneous drug reactions and 29% (9) had severe cutaneous drug reactions; 61.3% (19) were using aromatic AEDs, and the leading suspected AED was carbamazepine (45.2%). Comparison of patients who did and did not develop AED hypersensitivity showed that hypersensitivity was more frequent among patients who were younger than 12 years, who used aromatic AEDs, or who used multiple AEDs. In addition, according to regression analysis results, aromatic AED use significantly increased the risk of AED hypersensitivity (P < .001). CONCLUSIONS: Although allergic reactions to AEDs are rare, they are of significance because they can cause life-threatening severe cutaneous drug reactions. Therefore, patients receiving AEDs, especially aromatic AEDs, must be monitored closely. (C) 2018 American Academy of Allergy, Asthma & Immunology
引用
收藏
页码:2043 / 2050
页数:8
相关论文
共 50 条
  • [41] Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
    Koekkoek, Johan A. F.
    Kerkhof, Melissa
    Dirven, Linda
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vos, Maaike J.
    Bromberg, Jacoline E. C.
    van den Bent, Martin J.
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    BMC NEUROLOGY, 2014, 14
  • [42] Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
    Johan A F Koekkoek
    Melissa Kerkhof
    Linda Dirven
    Jan J Heimans
    Tjeerd J Postma
    Maaike J Vos
    Jacoline E C Bromberg
    Martin J van den Bent
    Jaap C Reijneveld
    Martin J B Taphoorn
    BMC Neurology, 14
  • [43] Immediate Hypersensitivity Reactions to Biologic Drugs in Children with Inflammatory Bowel Diseases
    Terece, Sinem Polat
    Karagol, Hacer Ilbilge Ertoy
    Duztas, Demet Teker
    Koken, Gizem
    Ozturk, Hakan
    Yapar, Dilek
    Gurkan, Odul Egritas
    Sari, Sinan
    Dalgic, Buket
    Bakirtas, Arzu
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024,
  • [44] Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany—a nationwide population-based study in children and adults
    Hajo M. Hamer
    Richard Dodel
    Adam Strzelczyk
    Monika Balzer-Geldsetzer
    Jens-Peter Reese
    Oliver Schöffski
    Wolfgang Graf
    Stefan Schwab
    Susanne Knake
    Wolfgang H. Oertel
    Felix Rosenow
    Karel Kostev
    Journal of Neurology, 2012, 259 : 2376 - 2384
  • [45] Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study
    Lin, C. -Y.
    Wang, C. -W.
    Hui, C. -Y. R.
    Chang, Y. -C.
    Yang, C. -H.
    Cheng, C. -Y.
    Chen, W. -W.
    Ke, W. -M.
    Chung, W. -H.
    ALLERGY, 2018, 73 (01) : 221 - 229
  • [46] Mortality in children with epilepsy.: A clinical-prospective study
    Devilat-Barros, M
    Rivera-Gómez, G
    Gómez-Muñoz, V
    Sepúlveda-Olmos, JP
    REVISTA DE NEUROLOGIA, 2004, 38 (07) : 607 - 614
  • [47] Seizure outcome after switching antiepileptic drugs: A matched, prospective study
    Finamore, Jon Marc
    Sperling, Michael R.
    Zhan, Tingting
    Nei, Maromi
    Skidmore, Christopher T.
    Mintzer, Scott
    EPILEPSIA, 2016, 57 (08) : 1294 - 1300
  • [48] A retrospective study on the usage of antiepileptic drugs in Asian children from 2000 to 2009 in the largest pediatric hospital in Singapore
    Tan, Wei Wei
    Kong, Sing Teang
    Chan, Derrick W. S.
    Ho, Paul C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (10) : 1074 - 1080
  • [49] Clinical and sonographic features predict testicular torsion in children: a prospective study
    Boettcher, Michael
    Krebs, Thomas
    Bergholz, Robert
    Wenke, Katharina
    Aronson, Daniel
    Reinshagen, Konrad
    BJU INTERNATIONAL, 2013, 112 (08) : 1201 - 1206
  • [50] Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications
    Baftiu, Arton
    Landmark, Cecilie Johannessen
    Rusten, Ida Rudberg
    Feet, Silje Andrea
    Johannessen, Svein I.
    Larsson, Pal G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (10) : 1245 - 1254